Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL

K-Number: K161928 · 2016-12-21

ApplicantSebia
Decision Date2016-12-21
Product CodeCFF
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL is a medical device manufactured by Sebia. It received FDA 510(k) clearance on 2016-12-21 under approval number K161928. The device is classified under product code CFF. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL?

CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL is a medical device that received FDA 510(k) clearance on 2016-12-21. It is manufactured by Sebia. The 510(k) number is K161928.

When was CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL approved by the FDA?

CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL received FDA 510(k) clearance on 2016-12-21, under approval number K161928.

What company makes CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL?

CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL is manufactured by Sebia.

What is the FDA product code for CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL?

The FDA product code for CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL is CFF.

Other Devices by Sebia

View all 12 devices →

Related Devices (Code: CFF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.